Thrombotic Microangiopathies
Top Cited Papers
- 22 August 2002
- journal article
- review article
- Published by Massachusetts Medical Society in New England Journal of Medicine
- Vol. 347 (8) , 589-600
- https://doi.org/10.1056/nejmra020528
Abstract
This article reviews the substantial progress made in understanding the thrombotic microangiopathies. The mechanisms of both thrombotic thrombocytopenic purpura and the hemolytic–uremic syndrome are considered.Keywords
This publication has 102 references indexed in Scilit:
- Response to Shiga Toxin-1, with and without Lipopolysaccharide, in a Primate Model of Hemolytic Uremic SyndromeAmerican Journal of Nephrology, 2001
- Hemolytic uremic syndrome: how do factor H mutants mediate endothelial damage?Trends in Immunology, 2001
- Aetiology and pathogenesis of thrombotic thrombocytopenic purpura and haemolytic uraemic syndrome: the role of von Willebrand factor-cleaving proteaseBest Practice & Research Clinical Haematology, 2001
- Factor H Mutations in Hemolytic Uremic Syndrome Cluster in Exons 18–20, a Domain Important for Host Cell RecognitionAmerican Journal of Human Genetics, 2001
- Clustering of Missense Mutations in the C-Terminal Region of Factor H in Atypical Hemolytic Uremic SyndromeAmerican Journal of Human Genetics, 2001
- Hemolytic-Uremic Syndrome and Complement Factor H Deficiency: Clinical AspectsSeminars in Thrombosis and Hemostasis, 2001
- von Willebrand factor-cleaving protease activity in congenital thrombotic thrombocytopenic purpuraBritish Journal of Haematology, 2000
- Thrombotic Thrombocytopenic Purpura Associated with ClopidogrelNew England Journal of Medicine, 2000
- Shear stress-induced binding of von willebrand factor to plateletsBiorheology, 1997
- Unusually Large Plasma Factor VIII: von Willebrand Factor Multimers in Chronic Relapsing Thrombotic Thrombocytopenic PurpuraNew England Journal of Medicine, 1982